Novozymes A/S (OTCMKTS:NVZMY) Releases Earnings Results, Misses Estimates By $0.16 EPS

Novozymes A/S (OTCMKTS:NVZMY) issued its quarterly earnings data on Thursday. The biotechnology company reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.16), Zacks reports. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.27 billion. Novozymes A/S had a net margin of 14.22% and a return on equity of 6.52%.

Novozymes A/S Price Performance

Shares of OTCMKTS:NVZMY opened at $70.51 on Friday. The company has a market capitalization of $29.23 billion, a PE ratio of 47.64, a price-to-earnings-growth ratio of 3.25 and a beta of 0.92. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.03 and a current ratio of 1.67. The stock has a fifty day moving average of $63.69 and a 200-day moving average of $60.59. Novozymes A/S has a one year low of $49.90 and a one year high of $75.27.

Analyst Ratings Changes

A number of analysts have commented on NVZMY shares. Kepler Capital Markets upgraded shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Zacks Research upgraded shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).